NEO
NEO
NASDAQ · Health Care

Neogenomics Inc

$7.75
+0.33 (+4.45%)
As of Apr 1, 8:20 PM ET ·
Financial Highlights (FY 2026)
Revenue
722.82M
Net Income
-107,357,307
Gross Margin
43.2%
Profit Margin
-14.9%
Rev Growth
+12.6%
D/E Ratio
0.41
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 43.2% 43.2% 50.1% 50.1%
Operating Margin -15.9% -14.3% 8.8% 8.7%
Profit Margin -14.9% -14.1% 7.4% 6.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 722.82M 642.05M 759.46M 804.45M
Gross Profit 312.33M 277.43M 380.80M 403.36M
Operating Income -115,145,077 -92,050,603 67.00M 69.80M
Net Income -107,357,307 -85,824,814 56.53M 50.19M
Gross Margin 43.2% 43.2% 50.1% 50.1%
Operating Margin -15.9% -14.3% 8.8% 8.7%
Profit Margin -14.9% -14.1% 7.4% 6.2%
Rev Growth +12.6% +12.6% -7.8% -8.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 143.47M 143.47M 99.64M 90.17M
Total Equity 351.12M 351.12M 945.36M 961.54M
D/E Ratio 0.41 0.41 0.11 0.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -79,362,676 -66,969,747 95.37M 98.54M
Free Cash Flow 21.30M 34.74M